Fund shareholders of REIN THERAPEUTICS INC
ISIN US00887A2042 · United States
- Fund shareholders
- 9
- Of which ETFs
- 2 7 other funds
- Value held
- 1.7M $
- Share of capital
- 1.5 % of 86.3M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 734,417 | 954.7K $ | 0.85 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 264,104 | 343.3K $ | 0.00 % | 0.31 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 113,421 | 129.3K $ | 0.00 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 67,187 | 76.6K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 64,973 | 84.5K $ | 0.01 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 35,242 | 40.2K $ | 0.04 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 27,869 | 31.8K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 8,122 | 9.3K $ | 0.01 % | as of Feb 28, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 3,982 | 5.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 9 | 0 | 1,319,317 | +3.8 % |
| 2026Q1 | 9 | 0 | 1,271,578 | +23.1 % |
| 2025Q4 | 9 | 0 | 1,033,279 | -9.5 % |
| 2025Q3 | 9 | -1 | 1,141,704 | +17.3 % |
| 2025Q2 | 10 | +2 | 973,458 | +42.2 % |
| 2025Q1 | 8 | 0 | 684,432 | +5.1 % |
| 2024Q4 | 8 | +2 | 651,257 | +13.3 % |
| 2024Q3 | 6 | -1 | 574,595 | +275.2 % |
| 2024Q2 | 7 | 0 | 153,163 | +8.8 % |
| 2024Q1 | 7 | 0 | 140,745 | +0.7 % |
| 2023Q4 | 7 | 139,805 |
Institutional managers
42 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Voss Capital, LP | 4,388,362 | 5.7M $ | as of Mar 31, 2026 |
| BIOS Capital Management, LP | 1,982,375 | 2.6M $ | as of Mar 31, 2026 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 511,610 | 665.1K $ | as of Mar 31, 2026 |
| Cable Car Capital, LP | 420,000 | 546K $ | as of Mar 31, 2026 |
| Prosight Management, LP | 411,600 | 535.1K $ | as of Mar 31, 2026 |
| Sigma Planning Corp | 348,677 | 453.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 344,690 | 448.2K $ | as of Mar 31, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 273,625 | 355.7K $ | as of Mar 31, 2026 |
| GAGNON SECURITIES LLC | 239,520 | 311.4K $ | as of Mar 31, 2026 |
| Senvest Management, LLC | 230,895 | 300.2K $ | as of Mar 31, 2026 |
| Palogic Value Management, L.P. | 180,000 | 234K $ | as of Mar 31, 2026 |
| ABS Direct Equity Fund LLC | 125,000 | 162.5K $ | as of Mar 31, 2026 |
| Rock Creek Group LLC | 125,000 | 162.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 75,904 | 98.7K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 68,528 | 89.1K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 64,136 | 83.4K $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 42,440 | 55.2K $ | as of Mar 31, 2026 |
| Chicago Partners Investment Group LLC | 41,048 | 77.2K $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 35,461 | 46.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 32,924 | 42.8K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 31,713 | 41.2K $ | as of Mar 31, 2026 |
| EXENCIAL WEALTH ADVISORS, LLC | 30,528 | 39.7K $ | as of Mar 31, 2026 |
| Meridian Wealth Advisors, LLC | 28,486 | 37K $ | as of Mar 31, 2026 |
| Americana Partners, LLC | 27,302 | 35.5K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 24,500 | 31.9K $ | as of Mar 31, 2026 |
Declared shareholders of REIN THERAPEUTICS INC
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Bios Fund I, LP and 23 others | 9.99 % | 7,797,502 | as of May 6, 2026 · SCHEDULE 13G |
| Funicular Funds, LP and 2 others | 6.70 % | 5,195,000 | as of May 1, 2026 · SCHEDULE 13G |
| Lynwood Capital Management Inc. and 2 others | 6.10 % | 4,750,000 | as of May 4, 2026 · SCHEDULE 13G |
| LYTTON LAURENCE W | 5.80 % | 4,500,000 | as of May 1, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of REIN THERAPEUTICS INC". https://titelia.com/en/stocks/rein-therapeutics-inc-US00887A2042